Quick Answer
Onconetix, Inc. reported Operating Income of -$17.86 million for fiscal year 2025.
Onconetix, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$17.86M | +68.4% |
| 2024 | -$56.49M | -56.8% |
| 2023 | -$36.03M | -167.3% |
| 2022 | -$13.48M | -294.5% |
| 2021 | -$3.42M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.07M | +21.8% | -6.9% |
| June 30, 2025 | -$1.94M | +85.8% | +84.6% |
| March 31, 2025 | -$12.57M | -13.4% | -375.1% |
| September 30, 2024 | -$2.65M | +41.0% | +80.6% |
| June 30, 2024 | -$13.62M | -104.7% | -22.9% |
| March 31, 2024 | -$11.08M | -289.1% | -146.9% |
| September 30, 2023 | -$4.49M | -16.0% | +32.5% |
| June 30, 2023 | -$6.65M | -54.8% | -133.5% |
- Onconetix, Inc. showed an increase of +68.4% in Operating Income compared to the prior fiscal year.
- Over the 2021–2025 period, Onconetix, Inc.’s operating income has declined by 422.5% (from -$3.42 million to -$17.86 million).
- The most recent figure is from Onconetix, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: